161 related articles for article (PubMed ID: 540199)
21. [Typical risks in the treatment of acute and chronic liver diseases].
Eisenburg J
Internist (Berl); 1982 Mar; 23(3):148-54. PubMed ID: 7042630
[No Abstract] [Full Text] [Related]
22. [Pathognomonic significance of increased ammonia levels].
Bosseckert H
Dtsch Med Wochenschr; 1999 Mar; 124(10):300. PubMed ID: 10215430
[No Abstract] [Full Text] [Related]
23. [Encephalopathy in chronic liver disease. Diagnosis and grading].
Van Waes L; De Loof JL; Demeulenaere L
Tijdschr Gastroenterol; 1978; 21(5):299-312. PubMed ID: 756092
[No Abstract] [Full Text] [Related]
24. Current status of the management of patients with portal hypertension.
Rikkers LF
Surg Annu; 1988; 20():179-200. PubMed ID: 3283964
[No Abstract] [Full Text] [Related]
25. [Internal therapy of portal hypertension].
Dölle W
Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():206-14. PubMed ID: 800909
[No Abstract] [Full Text] [Related]
26. [Pathogenesis and therapy of ascites in hepatic cirrhosis].
Persico L
Policlinico Prat; 1971 Feb; 78(3):100-9. PubMed ID: 5572866
[No Abstract] [Full Text] [Related]
27. Management of end-stage liver disease.
Chiou SS; Changchien CS
Transplant Proc; 1993 Oct; 25(5):2948-52. PubMed ID: 8212293
[No Abstract] [Full Text] [Related]
28. [Hepatic encephalopathy--therapy].
Wettstein M; Häussinger D
Dtsch Med Wochenschr; 2003 Dec; 128(50):2658-60. PubMed ID: 14673743
[No Abstract] [Full Text] [Related]
29. [Considerations on the treatment of edemato-ascitic syndromes of hepatic origin. Apropos of the utilization of an antialdosterone].
Levrat R; Savoye B; Imbert D
J Med Lyon; 1968 Dec; 49(154):1887-99. PubMed ID: 5712102
[No Abstract] [Full Text] [Related]
30. [Confusion and abnormal liver enzyme levels: problems with diagnosing hepatic encephalopathy].
Hendriks ME; van Westerloo DJ; Portegies P
Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2701-6. PubMed ID: 18225787
[TBL] [Abstract][Full Text] [Related]
31. Austrian consensus on the definition and treatment of portal hypertension and its complications.
Peck-Radosavljevic M; Trauner M; Schreiber F;
Endoscopy; 2005 Jul; 37(7):667-73. PubMed ID: 16010612
[No Abstract] [Full Text] [Related]
32. Hepatic encephalopathy: current status.
Schenker S; Breen KJ; Hoyumpa AM
Gastroenterology; 1974 Jan; 66(1):121-51. PubMed ID: 4588556
[No Abstract] [Full Text] [Related]
33. Gastrointestinal bleeding in patients with chronic liver disease: a review.
Wilson DE
J Assoc Acad Minor Phys; 1994; 5(2):50-8. PubMed ID: 8032176
[TBL] [Abstract][Full Text] [Related]
34. [Surgical implications of chronic liver diseases].
Kupcsulik P
Orv Hetil; 1992 Aug; 133(32):2001-6. PubMed ID: 1501850
[TBL] [Abstract][Full Text] [Related]
35. Analysis of a differential functional pattern between non-cirrhotic chronic liver disease and hepatic cirrhosis: a multivariate approach.
Coltorti M; Colombi A; Lucchelli PE; Budillon G; Di Simone A; Carrella M; Oriani GA
Rev Int Hepatol; 1969; 19(7):451-73. PubMed ID: 4102238
[No Abstract] [Full Text] [Related]
36. Intensive management of hepatic failure.
Rinella ME; Sanyal A
Semin Respir Crit Care Med; 2006 Jun; 27(3):241-61. PubMed ID: 16791758
[TBL] [Abstract][Full Text] [Related]
37. [Therapy of liver cirrhosis. Managing complications with fingertip control].
Mörk H
MMW Fortschr Med; 2001 Jul; 143(26-27):34-7. PubMed ID: 11481913
[TBL] [Abstract][Full Text] [Related]
38. Concept of the clinical stages of acute hepatic failure.
Komori H; Hirasa M; Takakuwa H; Ibuki Y; Kudo M; Fujimi K; Miyamura M; Tomita S; Todo A
Am J Gastroenterol; 1986 Jul; 81(7):544-9. PubMed ID: 3717116
[TBL] [Abstract][Full Text] [Related]
39. Favourable prognosis following variceal haemorrhage complicating hepatic sarcoidosis.
Mullins PD; Youngs GR
Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):185-6. PubMed ID: 7712312
[TBL] [Abstract][Full Text] [Related]
40. [Chronic liver disease].
Ueki A
Ryoikibetsu Shokogun Shirizu; 2003; (40):197-200. PubMed ID: 14626100
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
